Literature DB >> 33766079

Correction to: Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study.

Jia Yu1, Bo Qin1,2, Ann M Moyer3, Jason P Sinnwell4, Kevin J Thompson4, John A Copland5, Laura A Marlow5, James L Miller5, Ping Yin2, Bowen Gao6, Katherine Minter-Dykhouse2, Xiaojia Tang4, Sarah A McLaughlin7, Alvaro Moreno-Aspitia8, Anthony Schweitzer9, Yan Lu9, Jason Hubbard9, Donald W Northfelt10, Richard J Gray11, Katie Hunt12, Amy L Conners12, Vera J Suman4, Krishna R Kalari4, James N Ingle2, Zhenkun Lou2, Daniel W Visscher3, Richard Weinshilboum1, Judy C Boughey13, Matthew P Goetz1,2, Liewei Wang14.   

Abstract

Entities:  

Year:  2021        PMID： 33766079      PMCID： PMC7992984          DOI： 10.1186/s13058-021-01420-z

Source DB:  PubMed          Journal:  Breast Cancer Res        ISSN： 1465-5411            Impact factor:   6.466


× No keyword cloud information.
  1 in total

1.  Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study.

Authors:  Jia Yu; Bo Qin; Ann M Moyer; Jason P Sinnwell; Kevin J Thompson; John A Copland; Laura A Marlow; James L Miller; Ping Yin; Bowen Gao; Katherine Minter-Dykhouse; Xiaojia Tang; Sarah A McLaughlin; Alvaro Moreno-Aspitia; Anthony Schweitzer; Yan Lu; Jason Hubbard; Donald W Northfelt; Richard J Gray; Katie Hunt; Amy L Conners; Vera J Suman; Krishna R Kalari; James N Ingle; Zhenkun Lou; Daniel W Visscher; Richard Weinshilboum; Judy C Boughey; Matthew P Goetz; Liewei Wang
Journal:  Breast Cancer Res       Date:  2017-12-06       Impact factor: 6.466
  1 in total
  1 in total

1.  Analysis on factors behind sentinel lymph node metastasis in breast cancer by color ultrasonography, molybdenum target, and pathological detection.

Authors:  Aibibai Yiming; Muhetaer Wubulikasimu; Nuermaimaiti Yusuying
Journal:  World J Surg Oncol       Date:  2022-03-08       Impact factor: 2.754
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.